Document is current

Article History

Received: 20 January 2025

Accepted: 18 March 2025

First Online: 26 March 2025

Declarations

:

: S.S. and T.D.S. are consultants for Cytoki Pharma. S.D’A has received service fees from Cytoki Pharma, Dompè, Enthera, Ferring, Violicom, Novapep, Surrozen. A.D. has received honoraria as a speaker and/or advisory board member from AbbVie, Janssen, Pfizer, Takeda, and Tillots Pharma. A.L.K., R.J. and M.v.d.B. are employees of Cytoki Pharma. S.D. received honoraria as a speaker, consultant, and/or advisory board member from AbbVie, Alimentiv, Allergan, Amgen, Applied Molecular Transport, AstraZeneca, Athos Therapeutics, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Celltrion, Dr Falk Pharma, Eli Lilly, Enthera, Ferring Pharmaceuticals Inc., Gilead, Hospira, Inotrem, Janssen, Johnson & Johnson, Morphic, MSD, Mundipharma, Mylan, Pfizer, Roche, Sandoz, Sublimity Therapeutics, Takeda, Teladoc Health, TiGenix, UCB Inc., Vial, and Vifor.

: All studies in animals have been carried out in accordance with European Union legislation and have received ethical approval from the Italian Ministry of Health. The study involving human subjects has been carried out in accordance with the Declaration of Helsinki and was approved by the Central Denmark Region Ethics Committee (j. no. 1-10-72-362-21).

: Informed consent was obtained from all participants in the study involving human subjects after the nature and possible consequences of the study were explained.